HSP90B1 and neoplasm: The anti-tumor activity of a genetic vaccine candidate and saffron components were evaluated in vivo; mice were challenged subcutaneously with TC-1 tumor cells and on day 3 and 17 they were immunized with E7-NT (gp96) DNA.